| Dr Leonard Mark Dzubow, MD | |
|
101 Chesley Dr, Media, PA 19063-1761 | |
| (610) 566-7846 | |
| (610) 891-6735 |
| Full Name | Dr Leonard Mark Dzubow |
|---|---|
| Gender | Male |
| Speciality | Micrographic Dermatologic Surgery (mds) |
| Experience | 49 Years |
| Location | 101 Chesley Dr, Media, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790778199 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ND0101X | Dermatology - Mohs-micrographic Surgery | MD020065E (Pennsylvania) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dermatology Ltd | 0244120756 | 10 |
News Archive
One way of discovering a gene's function is to switch it off and observe how the loss of its activity affects an organism. If a gene is essential for survival, however, then switching it off permanently will kill the organism before the gene's function can be determined. Researchers at Cold Spring Harbor Laboratory (CSHL) have overcome this problem by using RNA interference (RNAi) technology to temporarily turn off any essential gene in adult mice and then turn it back on before the change kills the animals.
NJIT and UMDNJ have executed a license agreement with The Incubation Factory, St. Louis, MO, covering their personal tonometer technology on which a patent is pending. The tonometer was developed by a research team led by NJIT Professor Gordon Thomas, PhD, and Robert Fechtner, MD, director of the glaucoma division at UMDNJ.
Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced today that it has started its phase II clinical study of a vaccine for primary prevention of Clostridium difficile infection (CDI). The trial starting in the United States is focused on evaluating prevention of the first episode of CDI in at-risk individuals, which includes adults with imminent hospitalization or current or impending residence in a long-term care or rehabilitation facility.
Health Enhancement Products, Inc., in conjunction with Wayne State University's Department of Nutrition and Food Science in the College of Liberal Arts and Sciences, announces the publication of a scientific article in the Journal of Nutrition & Metabolism, "ProAlgaZyme sub-fraction improves the lipoprotein profile of hypercholesterolemic hamsters, while inhibiting production of betaine, carnitine, and choline metabolites."
The Alberta Pharmacists' Association (RxA) and the Canadian Association of Chain Drug Stores (CACDS) stated that they strongly support the new pharmacy funding and services model agreement announced today by Alberta Health and Wellness (AHW).
› Verified 2 days ago
| Entity Name | Dermatology Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477508257 PECOS PAC ID: 0244120756 Enrollment ID: O20040318000445 |
News Archive
One way of discovering a gene's function is to switch it off and observe how the loss of its activity affects an organism. If a gene is essential for survival, however, then switching it off permanently will kill the organism before the gene's function can be determined. Researchers at Cold Spring Harbor Laboratory (CSHL) have overcome this problem by using RNA interference (RNAi) technology to temporarily turn off any essential gene in adult mice and then turn it back on before the change kills the animals.
NJIT and UMDNJ have executed a license agreement with The Incubation Factory, St. Louis, MO, covering their personal tonometer technology on which a patent is pending. The tonometer was developed by a research team led by NJIT Professor Gordon Thomas, PhD, and Robert Fechtner, MD, director of the glaucoma division at UMDNJ.
Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced today that it has started its phase II clinical study of a vaccine for primary prevention of Clostridium difficile infection (CDI). The trial starting in the United States is focused on evaluating prevention of the first episode of CDI in at-risk individuals, which includes adults with imminent hospitalization or current or impending residence in a long-term care or rehabilitation facility.
Health Enhancement Products, Inc., in conjunction with Wayne State University's Department of Nutrition and Food Science in the College of Liberal Arts and Sciences, announces the publication of a scientific article in the Journal of Nutrition & Metabolism, "ProAlgaZyme sub-fraction improves the lipoprotein profile of hypercholesterolemic hamsters, while inhibiting production of betaine, carnitine, and choline metabolites."
The Alberta Pharmacists' Association (RxA) and the Canadian Association of Chain Drug Stores (CACDS) stated that they strongly support the new pharmacy funding and services model agreement announced today by Alberta Health and Wellness (AHW).
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Leonard Mark Dzubow, MD 101 Chesley Dr, Media, PA 19063-1761 Ph: (610) 566-7846 | Dr Leonard Mark Dzubow, MD 101 Chesley Dr, Media, PA 19063-1761 Ph: (610) 566-7846 |
News Archive
One way of discovering a gene's function is to switch it off and observe how the loss of its activity affects an organism. If a gene is essential for survival, however, then switching it off permanently will kill the organism before the gene's function can be determined. Researchers at Cold Spring Harbor Laboratory (CSHL) have overcome this problem by using RNA interference (RNAi) technology to temporarily turn off any essential gene in adult mice and then turn it back on before the change kills the animals.
NJIT and UMDNJ have executed a license agreement with The Incubation Factory, St. Louis, MO, covering their personal tonometer technology on which a patent is pending. The tonometer was developed by a research team led by NJIT Professor Gordon Thomas, PhD, and Robert Fechtner, MD, director of the glaucoma division at UMDNJ.
Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced today that it has started its phase II clinical study of a vaccine for primary prevention of Clostridium difficile infection (CDI). The trial starting in the United States is focused on evaluating prevention of the first episode of CDI in at-risk individuals, which includes adults with imminent hospitalization or current or impending residence in a long-term care or rehabilitation facility.
Health Enhancement Products, Inc., in conjunction with Wayne State University's Department of Nutrition and Food Science in the College of Liberal Arts and Sciences, announces the publication of a scientific article in the Journal of Nutrition & Metabolism, "ProAlgaZyme sub-fraction improves the lipoprotein profile of hypercholesterolemic hamsters, while inhibiting production of betaine, carnitine, and choline metabolites."
The Alberta Pharmacists' Association (RxA) and the Canadian Association of Chain Drug Stores (CACDS) stated that they strongly support the new pharmacy funding and services model agreement announced today by Alberta Health and Wellness (AHW).
› Verified 2 days ago
Dr. Karen Pearce Riggs, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 101 Chesley Dr, Suite Number 740, Media, PA 19063 Phone: 610-566-7846 Fax: 610-891-6735 | |
Dr. John Joseph Laskas, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 101 Chesley Dr, Suite 100, Media, PA 19063 Phone: 610-566-7111 Fax: 610-891-6735 | |
Dr. Joseph Peter Mcfarland, M.D. Dermatology Medicare: Medicare Enrolled Practice Location: 1078 W Baltimore Pike, Suite 204, Media, PA 19063 Phone: 610-565-6707 Fax: 610-565-6709 | |
Dr. Kelly Lynn Burkert, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 101 Chesley Dr, Media, PA 19063 Phone: 610-566-7846 Fax: 610-891-6735 | |
Gopal Atmaram Patel, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 176 S New Middletown Rd Ste 203, Media, PA 19063 Phone: 610-566-7300 Fax: 610-566-8973 | |
Dr. Edward Fung Chan, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 101 Chesley Dr, Suite 100, Media, PA 19063 Phone: 610-566-7111 Fax: 610-891-6735 | |
Elizabeth Marvin, Dermatology Medicare: Accepting Medicare Assignments Practice Location: 176 S New Middletown Rd Ste 203, Media, PA 19063 Phone: 610-566-7300 |